Skip to content
S/430S/430S/430

Drawing based on the label description. No photo yet.

“Ranitidine tablets, USP 300 mg (ranitidine HCI USP equivalent to 300 mg of ranitidine) are brown coloured, circular shaped, biconvex, beveled edge film-coated tablets debossed with "S/430" on one side and plain on the other side”

S 430 pill

Pill with imprint S 430 is brown, round, 13 mm and has been identified as Ranitidine 300 mg. It is used for acid reflux (GERD), ulcers and stomach ulcers. It is supplied by Aphena Pharma Solutions - Tennessee, LLC.

Ranitidine 300 mg

Imprint
S 430
Strength
300 mg
Used for
Acid reflux (GERD), ulcers and stomach ulcers
Color
Brown
Shape
Round
Size
13 mm
Score
No score line
Form
Tablet
Manufacturer
Aphena Pharma Solutions - Tennessee, LLC
Drug class
Acid reducer (H2 blocker)
NDC
71610-371, 51407-245, 71610-371-80

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Ranitidine pills and guides

What is Ranitidine used for?

Ranitidine is used for acid reflux (GERD), ulcers, stomach ulcers and Zollinger-Ellison syndrome.

Medicine type
Acid reducer (H2 blocker)
Official uses from the US prescribing label

Ranitidine Tablets are indicated in:

  1. Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks. Studies available to date have not assessed the safety of Ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks.
  2. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. No placebo – controlled comparative studies have been carried out for periods longer than 1 year.
  3. The treatment of pathological hypersecretory conditions. (e.g., Zollinger-Ellison syndrome and systemic mastocytosis).
  4. Short-term treatment of active, benign gastric ulcers. Most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. Studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks.
  5. Maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. Placebo-controlled studies have been carried out for 1 year.
  6. Treatment of GERD. Symptomatic relief commonly occurs within 24 hours after starting therapy with Ranitidine Tablets USP, 150 mg twice daily.
  7. Treatment of endoscopically diagnosed erosive esophagitis. Symptomatic relief of heartburn commonly occurs within 24 hours of therapy initiation with Ranitidine Tablets USP, 150 mg 4 times daily.
  8. Maintenance of healing of erosive esophagitis. Placebo-controlled trials have been carried out for 48 weeks.

​​​​​​​Concomitant antacids should be given as needed for pain relief to patients with active duodenal ulcer; active, benign gastric ulcer; hypersecretory states; GERD; and erosive esophagitis.

From the FDA-approved label on DailyMed (published Sep 25, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows S/430 and the other side is plain.
  • It is brown, round, 13 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Ranitidine Hydrochloride

Inactive: Magnesium Stearate, Cellulose, Microcrystalline, Croscarmellose Sodium, Silicon Dioxide, Hypromelloses, Titanium Dioxide, Triacetin, Ferric Oxide Red

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Ranitidine pills